Principle of the Assay: Aggregated Amyloid beta ELISA kit applies the competitive enzyme immunoassay technique utilizing a polyclonal anti-Aggregated Amyloid beta antibody and an Aggregated Amyloid beta-HRP conjugate. The assay sample and buffer are incubated together with Aggregated Amyloid beta-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the Aggregated Amyloid beta concentration since Aggregated Amyloid beta from samples and Aggregated Amyloid beta-HRP conjugate compete for the anti-Aggregated Amyloid beta antibody binding site. Since the number of sites is limited, as more sites are occupied by Aggregated Amyloid beta from the sample, fewer sites are left to bind Aggregated Amyloid beta-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The Aggregated Amyloid beta concentration in each sample is interpolated from this standard curve.
Principle of the Assay: Aggregated Amyloid beta ELISA kit applies the competitive enzyme immunoassay technique utilizing a polyclonal anti-Aggregated Amyloid beta antibody and an Aggregated Amyloid beta-HRP conjugate. The assay sample and buffer are incubated together with Aggregated Amyloid beta-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the Aggregated Amyloid beta concentration since Aggregated Amyloid beta from samples and Aggregated Amyloid beta-HRP conjugate compete for the anti-Aggregated Amyloid beta antibody binding site. Since the number of sites is limited, as more sites are occupied by Aggregated Amyloid beta from the sample, fewer sites are left to bind Aggregated Amyloid beta-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The Aggregated Amyloid beta concentration in each sample is interpolated from this standard curve.